Domestic equity benchmarks fell about half a percentage point each amid selling pressure in financial, IT, and oil and gas shares though buying interest in metal scrips lent some support. The Sensex gave up 386.5 points to end at 81,715.6 while the Nifty50 lost 112.6 points to 25,056.9, continuing to fall for the fourth trading session in a row. As investors await the next session on Dalal Street, here are a few stocks that are set to be in focus in Thursday’s trade:
Polycab block deal buzz
The company is set to undergo a block deal to the tune of Rs 880 crore where promoters are likely to offload 12 lakh shares at Rs 7,300 discount, marking a 3.1 per cent discount to the market price, according to Zee Business research.
Glenmark Pharma
Add Zee Business as a Preferred Source
The drug maker’s subsidiary, Glenmark Specialty SA, has signed an exclusive license and collaboration agreement with Hengrui Pharma for Trastuzumab Rezetecan (SHR-A1811), a cancer treatment medicine.
Defence PSU stocks BEL and HAL
HAL and BEL have secured deals amounting to Rs 6,400 crore from the IAF, sources told Zee Business.
Lupin
The US drug regulator has grants tentative approval for generic Biktarvy tablets to Lupin.
The Bictegravir, Emtricitabine and Tenofovir Alafenamide tablets are generics sed in the treatment of HIV.
Gujarat Pipavav Port
The company has secured a five-year deal with ONGC for a port and storage facility hiring in Pipavav, Gujarat.
Crisil
The rating agency’s board has approves the acquisition of 100 per cent in McKinsey PriceMetrix Co through step-down subsidiary Crisil Canada Inc.
The deal is estimated to be worth Rs 335 crore.
Waaree Energies
The company is set to invest a sum of Rs 300 crore in subsidiary Waaree Energy Storage Solutions through rights.
Radico Khaitan and Piccadily Agro
Piccadily Agro has won a lawsuit against Radico Khaitan in a trademark violation-related matter.
Radico’s brand name ‘KASHMYR’ was found to be similar to Piccadily’s registered brands ‘CASHMIR’ and ‘CASHMERE’.
The interim order restricts Radico from manufacturing, selling or advertising liquor under brandname ‘KASHMYR’ until final judgment.
ALSO READ: Swiggy eyes Rs 2,500 crore from Rapido stake sale—Should you buy, sell or hold?
Panacea Biotec
The company’s subsidiary, Panacea Biotec Pharma, has launched 100 per cent toxic-free products for babies.
Birla Corporation
The company’s subsidiary, RCCPL, has been declared the preferred bidder for a composite licence by the Telangana government.
NTPC
The PSU’s subsidiary, THDC India, has announced a COD of Unit II (660 MW) under the Khurja STPP (2X660 MW) project, with operations set to begin from September 26.
The NTPC group’s total installed and commercial capacity has risen to 83,696 MW.
Dalmia Bharat
The Enforcement Directorate has temporarily attached land and other assets amounting to Rs 793 crore linked to the company’s subsidiary, DCBL in a 2011 CBI case alleging irregularities in certain investments in Bharathi Cement.
Motilal Oswal Financial Services
The brokerage’s subsidiary has acquired 10,95,890 CCPS and 16.43 lakh shares in Kusumgar for Rs 100 crore.
Camlin Fine Sciences
The company’s board is set to meet on September 29 to consider equity share issuance through a private placement of shares for fundraising.
A preferential share swap for the Vinpai acquisition is also under consideration.
Cipla
The drug maker’s board is slated to meet on October 30 to review its Q2 results.
Torrent Pharmaceuticals
The drug maker has issues commercial papers to the tune of Rs 200 crore.
